Intuitive Machines: Backlog Is Surging While The Stock Sinks, Buy Into Q3

Intuitive Machines has a $1.8B backlog and new contract wins as civil and defense space missions accelerate. Adjusted EBITDA is expected to turn positive in EQ4'26, with margins projected to expand as production scales. Government funding shifts and dilution from ongoing capital raises are key risks.

Analysis

For LUNR, the key underwriting question is not the size of the backlog but how much is funded, executable, and convertible to cash on schedule. A large award pipeline can coexist with weak near-term economics if milestones slip, working capital absorbs cash, or contract scope carries unpriced execution risk. That makes share-count growth and cash conversion at least as important as reported contract wins.

Over the next 1–3 months, focus on updates to funded backlog, award timing, cash burn, and the fully diluted share count; government appropriations or procurement delays could quickly weaken the conversion case. Over 6–18 months, successful production scaling could improve operating leverage, while repeated schedule or cost overruns would undermine that thesis and could make further equity issuance more consequential. A potential second-order risk is that larger, better-capitalized space contractors capture follow-on work if LUNR cannot demonstrate reliable delivery; conversely, LUNR could benefit if customers seek additional providers rather than relying on a small number of primes.

The contrarian point is that a long-dated profitability target is not evidence of near-term self-funding. With no cash, dilution, or contract-funding detail supplied, the optimistic outlook does not by itself establish attractive risk/reward. Falsifiers: sustained improvement in cash conversion and funded backlog would support the bull case; rising dilution, deteriorating delivery milestones, or guidance slippage would invalidate it.

Key Decisions for Investors

• Do not chase on backlog headlines alone. Treat LUNR as a watchlist or small, risk-limited position until filings show funded backlog conversion, manageable cash use, and a stable diluted share count.
• At the next earnings or contract update, verify cash from operations, receivables and contract assets, funded versus conditional backlog, milestone timing, and share issuance. Escalate only if these improve alongside delivery execution.
• Set a thesis alert—not a price target—if management pushes out its profitability timeline, cuts delivery or revenue expectations, or raises capital faster than operating progress supports; reassess promptly.
• For a 6–18 month bullish position, require evidence of repeatable execution and cash conversion. Without that evidence, there is no compelling standalone trade from the supplied information.